ABCL
Price
$2.58
Change
+$0.06 (+2.37%)
Updated
Apr 24, 02:14 PM (EDT)
Capitalization
750.93M
14 days until earnings call
AURA
Price
$5.51
Change
-$0.25 (-4.34%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
286.79M
14 days until earnings call
Ad is loading...

ABCL vs AURA

Header iconABCL vs AURA Comparison
Open Charts ABCL vs AURABanner chart's image
AbCellera Biologics
Price$2.58
Change+$0.06 (+2.37%)
Volume$9.35K
Capitalization750.93M
Aura Biosciences
Price$5.51
Change-$0.25 (-4.34%)
Volume$9.23K
Capitalization286.79M
ABCL vs AURA Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. AURA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and AURA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ABCL: $2.54 vs. AURA: $5.76)
Brand notoriety: ABCL and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 101% vs. AURA: 57%
Market capitalization -- ABCL: $750.93M vs. AURA: $286.79M
ABCL [@Biotechnology] is valued at $750.93M. AURA’s [@Biotechnology] market capitalization is $286.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileAURA’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • AURA’s FA Score: 1 green, 4 red.
According to our system of comparison, ABCL is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while AURA’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • AURA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ABCL and AURA are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +6.28% price change this week, while AURA (@Biotechnology) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.56%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($751M) has a higher market cap than AURA($287M). ABCL YTD gains are higher at: -13.311 vs. AURA (-29.927). AURA has higher annual earnings (EBITDA): -91.84M vs. ABCL (-204.15M). ABCL has more cash in the bank: 626M vs. AURA (174M). AURA has less debt than ABCL: AURA (19.1M) vs ABCL (65.4M). ABCL has higher revenues than AURA: ABCL (28.8M) vs AURA (0).
ABCLAURAABCL / AURA
Capitalization751M287M262%
EBITDA-204.15M-91.84M222%
Gain YTD-13.311-29.92744%
P/E RatioN/AN/A-
Revenue28.8M0-
Total Cash626M174M360%
Total Debt65.4M19.1M342%
TECHNICAL ANALYSIS
Technical Analysis
ABCLAURA
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDVAX26.21N/A
N/A
Fidelity Advisor Diversified Intl A
MASCX11.19N/A
N/A
BlackRock Sustainable Advantage GlEqInvA
MSELX20.08N/A
N/A
Morgan Stanley Inst Emerging Mkts L
PRJDX39.89N/A
N/A
PGIM Jennison Global Opportunities R4
CCPCX12.79N/A
N/A
FS Chiron Capital Allocation C

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.79%
CRSP - ABCL
62%
Loosely correlated
-1.76%
NTLA - ABCL
59%
Loosely correlated
-2.65%
ABSI - ABCL
57%
Loosely correlated
-0.47%
BEAM - ABCL
57%
Loosely correlated
+3.87%
RXRX - ABCL
57%
Loosely correlated
-0.89%
More